Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (NY:BUD)

65.61 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Is It Too Late to Buy Tilray Brands Stock?
If this company can stage a comeback, it would be an incredible one. 
Via The Motley Fool
Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
Team up with the schoolyard bully so to speak with these compelling ideas for hedge fund favorite stocks to buy. 
Via InvestorPlace
TKO Group's NFLX deal is the knockout punch investors needed
TKO Group gapped up nearly 16% in record volume on the Netflix deal news before an ensuing low-volume pullback created what may be a favorable entry point 
Via MarketBeat
3 Cannabis Stocks to Buy in the ‘Green Zone’
It's now time to take a look at these three cannabis stocks to buy, as each one is currently within TradeSmith's "Green Zone." 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Bud Light To Make A Comeback At Super Bowl 2024 With Humorous Ad
The 60-second ad is part of a five-month campaign around the National Football League, which is part of a broader marketing push to revive the brand. 
Via Benzinga
Looking Into Anheuser-Busch InBev's Recent Short Interest
Via Benzinga
What Happened To Ab Inbev Stock After The Mulvaney Crisis?
Via Talk Markets
(BUD) - Analyzing Anheuser-Busch InBev's Short Interest
Via Benzinga
Conservative "Cannabis" Stocks Down Last Week; What You Need To Know
The 5 tobacco, beer, and distiller/vintner companies with major investments in the cannabis sector are highlighted with their performances last week, their current dividend yields, P/E and PEG ratios,... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
This Cannabis Giant Only Generates 35% of Its Revenue From Its Marijuana Products. Here's Where the Rest Comes From.
In addition to cannabis, Tilray has alcohol, distribution, and wellness segments. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
The 3 Most Undervalued Cannabis Stocks to Buy in January
Cannabis stocks are ready to rebound on the heels of rescheduling rumors, so pick stocks that have solid differentiation from competitors. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Tilray CEO Irwin Simon Is Buying Up TLRY Stock
Tilray CEO Irwin Simon has shown his conviction in the company by making his first insider buy of TLRY stock in almost four years. 
Via InvestorPlace
Billionaire Investor Chamath Palihapitiya's New AI Venture Could Kill Software Companies, Mark Cuban Says Not So Fast
Chamath Palihapitiya has a new business proposal that uses artificial intelligence to help companies save on software expenses. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Looking At Anheuser-Busch InBev's Recent Unusual Options Activity
Via Benzinga
Beer Is The Only Thing Constellation Brands Does Not Have To Worry About
On Friday, Constellation Brands (NYSE: STZ) reported its third quarter financials that fell short of expectations as persistently high inflation slowed down the demand for its high-priced spirits. 
Via Benzinga
Topics Economy
Exposures Interest Rates
International Olympic Committee and AB InBev Announce Worldwide Olympic Partnership
From Anheuser-Busch InBev
Via Business Wire
Urban Outfitters To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Mixed Bag For Constellation Brands: Earnings Reveal Strong Profits Amid Sales Forecast Cut
Constellation Brands reports strong Q3 profits with $509.1M income but revises sales forecast amid market shifts. Explore more! 
Via Benzinga
Tilray’s Downfall: Why TLRY Stock Isn’t the High Investors Hoped For
Investors should run, not walk, from this cannabis producer, which seemingly has insurmountable challenges. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors
Gen Z stocks include companies the generation prefers to invest in while capturing the emerging economic force they represent. 
Via InvestorPlace
New Year Resolution Stocks: Can Getting Fitter Be A Winner On The Stock Market?
Novo Nordisk's shares gained 50.7% in 2023 thanks largely to sales of its weight loss drugs, while Eli Lilly's shares have jumped 60.7%. 
Via Benzinga
Investors Love Altria's 10%-Yielding Dividend: Is There Hope for More in 2024?
Altria has relied on the golden goose of cigarette sales for decades. But that's also why the stock has disappointed in recent years. 
Via The Motley Fool
Looking Beyond The 'Magnificent 7' — Analysts Just Upgraded These Three Large-Cap Stocks
Via Benzinga
From Snoop Dogg Video Blasting Trump To GOP Admitting Legal Weed Undercuts Drug Cartels: Benzinga's Most-Read Pot Stories Of 2023
What was the most exciting cannabis news of 2023?  
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Want Decades of Passive Income? 3 Stocks to Buy Now
Consider this tobacco dividend king, "the monthly dividend company," and a big index fund. 
Via The Motley Fool
Conservative "Cannabis" Stocks Index Down Slightly In December And YTD
The stock returns of the 5 tobacco, beer, and distiller/vintner companies with major investments in the cannabis sector are down slightly MTD and YTD, on average. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
2 Great Value Stocks To Buy For 2024
Investors might want to consider buying stocks outside of technology heading into 2024. 
Via Talk Markets
Canopy Growth Just Enacted a 1-for-10 Reverse Split of CGC Stock
Profits have proven elusive in the marijuana sector. Canopy rival Tilray Brands has shifted its attention to beer. CGC stock has languished. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Better Growth Stock: Canopy Growth vs. Tilray Brands
Should you go with the U.S.-focused cannabis business or the company with broader diversification? 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Budweiser Parent AB InBev Exits Russia, Hands Over Joint Venture To Turkish Partner: Report
Anheuser-Busch InBev SA (NYSE: BUD) has reportedly reached an agreement to transfer its stake in a Russian joint venture to its Turkish partner, Anadolu Efes. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.